Zöller M
Int J Cancer. 1986 Jan 15;37(1):133-40. doi: 10.1002/ijc.2910370121.
After in vitro stimulation of lymphocytes with syngeneic tumor cells in the presence of interleukin 2 (IL-2), a cytotoxic T-cell response was observed against these spontaneously arising BDX tumors, which are non-immunogenic in the syngeneic host. The response was due to cytotoxic T-cells (CTL), which were specific for syngeneic tumor cells, i.e. neither syngeneic lymphoblasts, allogeneic lymphoblasts, allogeneic tumor cells, nor NK targets were lysed. The frequencies of anti-tumor lymph-node (LN) and spleen CTL precursors (CTLp) against a panel of syngeneic tumors of different histology varied between 1/6,000 and 1/16,000. Further analysis of the reactivity pattern of anti-tumor CTL revealed some degree of cross-reactivity within the syngeneic system. By a limiting dilution (LD) split culture approach in combination with cold target (CT) inhibition, it could be shown that tumors carry a panel of tumor-associated antigens (TAAs). Some tumors express individually specific as well as cross-reactive TAAs, while others carry cross-reactive TAAs only.
在白细胞介素2(IL-2)存在的情况下,用同基因肿瘤细胞对淋巴细胞进行体外刺激后,观察到针对这些在同基因宿主中无免疫原性的自发产生的BDX肿瘤的细胞毒性T细胞反应。该反应归因于细胞毒性T细胞(CTL),其对同基因肿瘤细胞具有特异性,即同基因淋巴母细胞、异基因淋巴母细胞、异基因肿瘤细胞或NK靶细胞均未被裂解。针对一组不同组织学类型的同基因肿瘤的抗肿瘤淋巴结(LN)和脾脏CTL前体(CTLp)的频率在1/6,000至1/16,000之间变化。对抗肿瘤CTL反应模式的进一步分析揭示了同基因系统内一定程度的交叉反应性。通过有限稀释(LD)分割培养方法结合冷靶(CT)抑制,可以证明肿瘤携带一组肿瘤相关抗原(TAA)。一些肿瘤表达单独特异性以及交叉反应性TAA,而其他肿瘤仅携带交叉反应性TAA。